Allecra Therapeutics Announces Late-breaker Presentation of Phase 3 ALLIUM Trial with Cefepime-Enmetazobactam in cUTIs at IDWeek 2020

Written by Petra Hegmann on 23rd October 2020. Posted in Client News.

• Previous
• Next